ProfileGDS5822 / ILMN_2434289
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 43% 49% 37% 53% 25% 17% 48% 3% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 119.143
GSM1276600PDAC Late Ablation Control 223.649
GSM1276601PDAC Late Ablation Control 3
GSM1276602PDAC Late Ablation 115.237
GSM1276603PDAC Late Ablation 22553
GSM1276604PDAC Late Ablation 313.725
GSM1303940PDAC Late Ablation_anti-CTLA4 11217
GSM1303941PDAC Late Ablation_anti-CTLA4 223.548
GSM1303942PDAC Late Ablation_anti-CTLA4 32.83